earnings
confidence high
sentiment positive
materiality 0.75
Abbott Q1 revenue $9.7B, adj EPS $1.03; base business organic growth 10.0%
ABBOTT LABORATORIES
2023-Q1 EPS reported
$0.75
revenue$9,747,000,000
- Q1 GAAP EPS $0.75; adjusted EPS $1.03; revenue $9.747B, down 18.1% reported, but organic base business up 10.0%.
- Full-year 2023 adjusted EPS guidance unchanged at $4.30-$4.50; COVID testing-related sales forecast ~$1.5B.
- Medical Devices organic sales grew 12.4%; FreeStyle Libre sales $1.2B with ~50% U.S. growth.
- Nutrition organic sales up 10.3% (Pediatric +18.4% organic); Diagnostics ex-COVID tests organic +4.4%.
- Dividend of $0.51/share declared, payable May 15; 51 consecutive years of dividend increases.